Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

Mabel K. Yan; Rory Wolfe; Suzanne G. Orchard; Michael E. Ernst; Victoria J. Mar

doi:10.1111/ajd.13727

Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

Mabel K. Yan
, Rory Wolfe
, Suzanne G. Orchard
, Michael E. Ernst
, Victoria J. Mar

Research output: Contribution to journal › Letter › Research › peer-review

Original language	English
Pages (from-to)	114-115
Number of pages	2
Journal	Australasian Journal of Dermatology
Volume	63
Issue number	1
DOIs	https://doi.org/10.1111/ajd.13727
Publication status	Published - Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

adverse effects
melanoma
methotrexate
risk
skin cancer

Access to Document

10.1111/ajd.13727

Cite this

@article{1165ce8442da4155a5a33560c8b83af5,

title = "Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial",

keywords = "adverse effects, melanoma, methotrexate, risk, skin cancer",

author = "Yan, \{Mabel K.\} and Rory Wolfe and Orchard, \{Suzanne G.\} and Ernst, \{Michael E.\} and Mar, \{Victoria J.\}",

note = "Funding Information: We acknowledge the ASPREE Cancer Endpoint Adjudication Committee who reviewed and confirmed all cancer events. M.Y is supported by an Australian Government Research Training Program Scholarship. The ASPREE trial was supported by a grant (U01AG029824) and the extension study (ASPREE‐XT) is supported by a grant (U19AG062682) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2022",

month = feb,

doi = "10.1111/ajd.13727",

language = "English",

volume = "63",

pages = "114--115",

journal = "Australasian Journal of Dermatology",

issn = "0004-8380",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Effect of methotrexate on melanoma risk in older adults

T2 - Secondary analysis of a randomised controlled trial

AU - Yan, Mabel K.

AU - Wolfe, Rory

AU - Orchard, Suzanne G.

AU - Ernst, Michael E.

AU - Mar, Victoria J.

N1 - Funding Information: We acknowledge the ASPREE Cancer Endpoint Adjudication Committee who reviewed and confirmed all cancer events. M.Y is supported by an Australian Government Research Training Program Scholarship. The ASPREE trial was supported by a grant (U01AG029824) and the extension study (ASPREE‐XT) is supported by a grant (U19AG062682) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the National Health and Medical Research Council of Australia, and by Monash University and the Victorian Cancer Agency. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2022/2

Y1 - 2022/2

KW - adverse effects

KW - melanoma

KW - methotrexate

KW - risk

KW - skin cancer

UR - https://www.scopus.com/pages/publications/85115825055

U2 - 10.1111/ajd.13727

DO - 10.1111/ajd.13727

M3 - Letter

C2 - 34581443

AN - SCOPUS:85115825055

SN - 0004-8380

VL - 63

SP - 114

EP - 115

JO - Australasian Journal of Dermatology

JF - Australasian Journal of Dermatology

IS - 1

ER -

Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

UN SDGs

Keywords

Access to Document

Other files and links

ASPREE Completion Project

Cite this

Effect of methotrexate on melanoma risk in older adults: Secondary analysis of a randomised controlled trial

UN SDGs

Keywords

Access to Document

Other files and links

Projects

ASPREE Completion Project

Cite this